Fierce Biotech Webinar “Alzheimer’s Outlook – Neuroinflammation, the Next Step” is now available on demand.
InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, joins a panel of experts to speak about recent breakthroughs in Alzheimer’s disease research and the effects of neuroinflammation in disease progression.
Access free webinar here (available until May 12, 2025): https://www.fiercebiotech.com/premium/webinar/breakthroughs-alzheimers-research-and-drug-development
Alzheimer’s disease research experts come together for this informative session. Learn about:
- Role of neuroinflammation in the development of cognition-impairing disease
- Biological pathways to developing drugs to address neuroinflammation
- Why neuroinflammation is an important target for novel Alzheimer’s treatments
- Importance of patient diversity in clinical trial design
- Scanning the horizon – what to expect in the next 5 years
If you are a neurodegenerative disease researcher or clinician or study brain health or are a caregiver for someone living with Alzheimer’s disease, watch this webinar to learn what the future holds in Alzheimer’s disease therapeutic development.
Speakers for this event:
- Phyllis Ferrell, DrPH, MBA (Moderator), Chief Impact Officer at StartUp Health’s Alzheimer’s Moonshot
- David Morgan, PhD, Director of the Alzheimer’s Alliance and MSU Foundation Professor of Translational Neuroscience at Michigan State University
- Marwan Sabbagh, MD, Moreno Family Chair for Alzheimer’s Research and Vice Chairman for Research and Professor of Neurology at the Barrow Neurological Institute in Phoenix Arizona
- Barry Greenberg, PhD, Associate Professor in the Department of Neurology and Director of Alzheimer’s Disease Translational Center at the Johns Hopkins University School of Medicine
- Eric Hsu, PhD, Senior Vice President of Preclinical Research and Development at InMed Pharmaceuticals
